The effect of mesenchymal stem cells on amniotic membrane

Not Applicable

• Conditions: Chronic wound.; Chronic ulcer of skin, not elsewhere classified; L98.4

• Registration Number: IRCT20090128001605N18
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Age between 20-60 years old
Chronic wound less than 1% of the body surface due to vascular causes (arterial, venous and lymphatic), diabetic, radiotherapy, subcutaneous wound

Exclusion Criteria

Pregnant Women
Any patients that is treated with medicine that causes wound healing disorder, malignancy, or osteomyelitis in the wound

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound surface. Timepoint: The wounds will covered by acellular amniotic membrane seeded with WJSCs for 9 days, every 3 days with a follow up of one month. Method of measurement: Pellany Metric Software.

Secondary Outcome Measures

Name	Time	Method
The duration of wound healing. Timepoint: The wounds will cover by acellular amniotic membrane seeded with WJSCs for 9 days, every 3 days with a follow up of one month. Method of measurement: Days.